Wide Ranks

BMEA

Biomea Fusion, Inc.

7.02

Top Statistics
Market Cap 254 M Forward PE -2.28 Revenue Growth 0.00 %
Current Ratio 3.40 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -1.18 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 87 M Total Cash Per Share 2.43 Total Debt 9 M
Total Debt To Equity 12.59 Current Ratio 3.40 Book Value Per Share 2.10
All Measures
Short Ratio 1184.00 % Message Board Id finmb_695310535 Shares Short Prior Month 8 M
Return On Equity -1.05 City Redwood City Uuid bc0a49f6-c4ed-3d62-b67c-2f5f0de07165
Previous Close 6.89 First Trade Date Epoch Utc 1 B Book Value 2.10
Beta -0.4270 Total Debt 9 M Volume 271339
Price To Book 3.35 Fifty Two Week Low 3.61 Total Cash Per Share 2.43
Shares Short Previous Month Date 1 B Target Median Price 40.00 Max Age 86400
Recommendation Mean 1.78 Sand P52 Week Change 0.3133 Target Mean Price 42.89
Net Income To Common -144008000 Short Percent Of Float 0.4227 Implied Shares Outstanding 36 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 605870
Average Volume10days 605870 Total Cash 87 M Next Fiscal Year End 1 B
Held Percent Insiders 0.2501 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 6.89 Target Low Price 11.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 9.32 Open 7.02
Free Cashflow -65435500 State CA Dividend Yield 0.00 %
Return On Assets -0.5638 Time Zone Short Name EST Trailing Eps -4.01
Day Low 6.76 Address1 900 Middlefield Road Shares Outstanding 36 M
Price Hint 2 Target High Price 128.00 Website https://biomeafusion.com
52 Week Change -0.5342 Average Volume 778226 Forward Eps -3.32
Recommendation Key buy Compensation As Of Epoch Date 1 B Quick Ratio 319.00 %
Is_sp_500 False Regular Market Day High 7.10 Profit Margins 0.00 %
Debt To Equity 12.59 Fifty Two Week High 22.74 Day High 7.10
Shares Short 9 M Regular Market Open 7.02 Industry Key biotechnology
Earnings Growth 0.00 % Revenue Growth 0.00 % Shares Percent Shares Out 0.2596
Operating Cashflow -112727000 Currency USD Time Zone Full Name America/New_York
Market Cap 254 M Is_nasdaq_100 False Zip 94063
Quote Type EQUITY Industry Biotechnology Long Name Biomea Fusion, Inc.
Regular Market Day Low 6.76 Held Percent Institutions 0.6453 Current Price 7.02
Address2 4th Floor Enterprise To Ebitda -1.18 Financial Currency USD
Current Ratio 3.40 Industry Disp Biotechnology Number Of Analyst Opinions 9
Country United States Float Shares 22 M Two Hundred Day Average 9.81
Enterprise Value 176 M Forward PE -2.28 Regular Market Volume 271339
Ebitda -149624992 Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases.

Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes.

The company was incorporated in 2017 and is headquartered in Redwood City, California.